ABSTRACT Alopecia areata (AA) is a complex, chronic inflammatory skin disorder characterized by unpredictable, nonscarring hair loss, affecting millions worldwide
Sarah Johnson, an endocrinologist specializing in metabolic disorders, notes: For patients with multiple metabolic concernsparticularly those with a family history of diabetesI often start with a GLP-1 medication and then reassess lipid levels after 3-4 months
Metabolic Improvements Beyond appetite and digestion, these medications also offer metabolic benefits: Enhanced insulin sensitivity Better glucose management Reduced inflammation Improved cardiovascular markers in many patients These metabolic improvements create a more favorable internal environment for weight management and overall health
This is challenging when appetite is suppressed, which is why protein shakes formulated for GLP-1 users become valuable tools
Additionally, both can increase heart rate slightly and may trigger pancreatitis in rare cases, signaled by severe upper abdominal pain, persistent vomiting, or back pain